AND MABs & Biologics are the new gold standard of care in not only cancer but other immunological diseases from chronic urticaria, severe eczema, severe asthma and others, just a few examples and a miracle for many, some still in trial stages.
It’s the way forward in treatment targeting immune response in many chronic diseases. I read Pharma news, not all MABs & Biologics get through phase 1 with safety. IMU are the B cell giants owning USA research too in Mayo clinic & others with all that IP. We got through that $20 million CR to hold all relevant B cell technology in vacccines. Let’s not forget this part of IMU story either, because it’s rather important.
From the website 17/12, page-39
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
